Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:12 pm Purchase | 13G | REGENERON PHARMACEUTICALS INC REGN | VANGUARD GROUP INC | 8,838,240 8.25% | 115,792 (+1.33%) | View |
| 2024-02-09 6:19 pm Sale | 13G | REGENERON PHARMACEUTICALS INC REGN | Capital World Investors | 5,194,729 4.8% | -1,121,090 (-17.75%) | View |
| 2024-02-09 09:49 am Sale | 13G | REGENERON PHARMACEUTICALS INC REGN | FMR LLC | 10,317,407 9.63% | -779,577 (-7.03%) | View |
| 2024-01-25 4:59 pm Sale | 13G | REGENERON PHARMACEUTICALS INC REGN | BlackRock Inc. BLK | 8,629,707 8.1% | -537,110 (-5.86%) | View |
| 2024-01-25 11:11 am Unchanged | 13G | REGENERON PHARMACEUTICALS INC REGN | JPMORGAN CHASE & CO JPM | 7,219,436 6.7% | 0 (Unchanged) | View |
| 2024-01-25 11:10 am Purchase | 13G | REGENERON PHARMACEUTICALS INC REGN | JPMORGAN CHASE & CO JPM | 7,219,436 6.7% | 1,118,392 (+18.33%) | View |
| 2023-09-27 4:05 pm Sale | 13D | DECIBEL THERAPEUTICS INC DBTX | REGENERON PHARMACEUTICALS INC. REGN | 100 100% | -2,097,214 (-100.00%) | View |
| 2023-08-18 5:16 pm Unchanged | 13D | DECIBEL THERAPEUTICS INC DBTX | REGENERON PHARMACEUTICALS INC. REGN | 2,097,314 8.3% | 0 (Unchanged) | View |
| 2023-02-13 2:49 pm Purchase | 13G | REGENERON PHARMACEUTICALS INC REGN | Capital World Investors | 6,315,819 5.9% | 923,949 (+17.14%) | View |
| 2023-02-09 12:31 pm Purchase | 13G | REGENERON PHARMACEUTICALS INC REGN | FMR LLC | 11,096,984 10.362% | 287,238 (+2.66%) | View |
| 2023-02-09 11:30 am Purchase | 13G | REGENERON PHARMACEUTICALS INC REGN | VANGUARD GROUP INC | 8,722,448 8.15% | 563,933 (+6.91%) | View |
| 2023-02-03 4:27 pm Sale | 13G | REGENERON PHARMACEUTICALS INC REGN | BlackRock Inc. BLK | 9,166,817 8.6% | -444,054 (-4.62%) | View |
| 2023-01-11 12:09 pm Purchase | 13G | REGENERON PHARMACEUTICALS INC REGN | JPMORGAN CHASE & CO JPM | 6,101,044 5.6% | 6,101,044 (New Position) | View |
| 2022-10-11 09:03 am Purchase | 13G | REGENERON PHARMACEUTICALS INC REGN | FMR LLC | 10,809,746 10.084% | 746,781 (+7.42%) | View |
| 2022-02-11 4:07 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | REGENERON PHARMACEUTICALS INC. REGN | 1,809,098 1.84% | 1,809,098 (New Position) | View |
| 2022-02-11 4:06 pm Purchase | 13G | INTELLIA THERAPEUTICS INC NTLA | REGENERON PHARMACEUTICALS INC. REGN | 3,702,995 4.98% | 925,218 (+33.31%) | View |
| 2022-02-11 4:05 pm Purchase | 13G | DECIBEL THERAPEUTICS INC DBTX | REGENERON PHARMACEUTICALS INC. REGN | 2,097,314 8.42% | 2,097,314 (New Position) | View |
| 2022-02-11 2:48 pm Sale | 13G | REGENERON PHARMACEUTICALS INC REGN | Capital World Investors | 5,391,870 5.1% | -1,625,252 (-23.16%) | View |
| 2022-02-10 08:32 am Purchase | 13G | REGENERON PHARMACEUTICALS INC REGN | VANGUARD GROUP INC | 8,158,515 7.72% | 227,295 (+2.87%) | View |
| 2022-02-09 10:24 am Sale | 13G | REGENERON PHARMACEUTICALS INC REGN | FMR LLC | 10,062,965 9.518% | -1,418,606 (-12.36%) | View |